High dose N-acetylcysteine to prevent pulmonary complications in partial or total transthoracic esophagectomy: Results of a prospective observational study

Diseases of the Esophagus

Volumn 20, Issue 5, 2007, Pages 399-405

  Zingg, Urs ^a,c   Hofer, C K ^a   Seifert, B ^b   Metzger, U ^a   Zollinger, A ^a  

^a TRIEMLI HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Esophagectomy; N acetylcysteine; Oxygenation; Pulmonary complications

Indexed keywords

ACETYLCYSTEINE; CYTOKINE; OXYGEN; SCAVENGER;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ATELECTASIS; BREATHING MECHANICS; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG MEGADOSE; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; INFORMATION PROCESSING; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; KAPLAN MEIER METHOD; LENGTH OF STAY; LUNG DISEASE; LUNG FUNCTION; MALE; MORBIDITY; NUTRITIONAL STATUS; OBSERVATIONAL STUDY; OXYGENATION; PERIOPERATIVE PERIOD; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SOCIAL ASPECT; SURGICAL APPROACH; SURVIVAL RATE; TREATMENT OUTCOME;

ACETYLCYSTEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; FREE RADICAL SCAVENGERS; HUMANS; LENGTH OF STAY; LUNG DISEASES; MALE; MIDDLE AGED; OXYGEN; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34548282145     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00690.x     Document Type: Article

References (36)

1. Avendano C E, Flume P E, Silvestri G A, King L B, Reed C E. Pulmonary complications after esophagectomy. Ann Thorac Surg 2002; 73: 922-6.
2. Griffin S M, Shaw I H, Dresner S M. Early complications after Ivor-Lewis subtotal esophagectomy with two field lymphadenectomy: Risk factors and management. J Am Coll Surg 2002; 194: 285-97.
3. Paul S, Bueno R. Complications following esophagectomy: Early detection, treatment, prevention. Sem Thorac Cardiovasc Surg 2003; 15: 210-15.
4. Bolton J S, Teng S. Transthoracic or transhiatal esophagectomy for cancer of the esophagus -does it matter. Surg Oncol Clin N Am 2002; 11: 365-75.
5. Enzinger P C, Mayer R J. Esophageal cancer. N Engl J Med 2003; 349: 2241-52.
6. Lerut T, Coosemans W, Decker G et al. Extended surgery for cancer of the esophagus and gastroesophageal junction. J Surg Res 2004; 117: 58-63.
7. Lerut T, Nafteux P, Moons J et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: Impact on staging, disease-free survival, and outcome. Ann Surg 2004; 240: 962-74.
8. Marton S, Szakmany T, Papp A, Cseke L, Horvath P O. Does transthoracic compared to transhiatal resection alter the early post-operative course of esophagectomy? Dis Esophagus 2005; 18: 155-9.
9. Gockel I, Heckhoff S, Messow C M, Kneist W, Junginger T. Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: Does the operative approach have influence on long-term prognosis? World J Surg Oncol 2005; 3: 40-51.
10. Gockel I, Exner C, Junginger T. Morbidity and mortality after esophagectomy for esophageal carcinoma: A risk analysis. World J Surg Oncol 2005; 3: 37-40. analysis
11. Aleksic M, Wolf B, Ulrich B. Ergebnisse der chirurgischen Therapie des Oesophaguscarcinoms am Allgemeinkrankenhaus. Chirurg 1995; 66: 1247-53.
12. Bonavina L, Incarbone R, Saino G, Clesi P, Peracchia A. Clinical outcome and survival after esophagectomy for carcinoma in elderly patients. Dis Esophagus 2003; 16: 90-3.
13. Crozier T A, Sydow M, Siewert J R, Braun U. Postoperative pulmonary complication rate and long-term changes in respiratory function following esophagectomy with esophagogastrostomy. Acta Anaesthesiol Scand 1992; 36: 10-15.
14. Ferguson M K, Durkin A E. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg 2001; 123: 661-8.
15. Bernard G R, Lucht W D, Niedermeyer M E et al. Effect of N-acetylcysteine on pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J Clin Invest 1984; 73: 1772-84.
16. Heller A R, Groth G, Heller S C et al. N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients. Crit Care Med 2001; 29: 272-6.
17. Laurent T, Markert M, Feihl F, Schaller M D, Perret C. Oxidant-antioxidant balance in granulocytes during ARDS. Effect N-acetylcysteine. Chest 1996; 109: 163-6.
18. Molnar Z, Shearer E, Lowe D. N-acetylcysteine treatment to prevent the progression of multisystem organ failure: A prospective, randomized, placebo-controlled study. Crit Care Med 1999; 27: 1100-4.
19. Paterson R L, Galley H F, Webster N R. The effect of N-acetylcysteine on nuclear factor-κB activation, interleukin-6, interleukin-8, and intracellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med 2003; 31: 2574-8.
20. Suter P M, Domenighetti G et al. N-acetylcysteine enhances recovery from acute lung injury in man. Chest 1994; 105: 190-4.
21. Bernard G R, Wheeler A P et al. A trial of antioxidants N-acetylcysteine and Procysteine in ARDS. Chest 1997; 112: 164-72.
22. Domenighetti G, Suter P M, Schaller M D, Ritz R, Perret C. Treatment with N-acetylcysteine during acute respiratory distress syndrome: A randomized, double-blind, placebo-controlled clinical study. J Crit Care 1997; 12: 177-82.
23. Bernard G R, Artigas A, Brigham K L et al. The American-European consensus conference on ARDS. Am J Respir Crit Care Med 1994; 149: 818-24.
24. Smetana G W. Preoperative pulmonary evaluation. N Engl J Med 1999; 340: 937-44.
25. Gillinov A M, Heitmiller R F. Strategies to reduce pulmonary complications after transhiatal esophagectomy. Dis Esophagus 1998; 11: 43-7.
26. Bishop D G M, McKeown K C. Postoperative hypoxaemia: Oesophagectomy with gastric replacement. Br J Surg 1979; 66: 810-12.
27. Fagevik Olson M, Wennberg E, Johnsson E, Josefson K, Lönroth H, Lundell L. Randomized clinical study of the prevention of pulmonary complications after thoracoabdominal resection by two different breathing techniques. Br J Surg 2002; 89: 128-34.
28. Abe T, Oka M, Tangoku A et al. Interleukin-6 production in lung tissue after transthoracic esophagectomy. J Am Coll Surg 2001; 192: 322-9.
29. Kooguchi K, Kobayashi A, Kitamura Y et al. Elevated expression of inducible nitric oxide synthase and inflammatory cytokines in the alveolar macrophages after esophagectomy. Crit Care Med 2002; 30: 71-6.
30. Sakamoto K, Arakawa H, Mita S et al. Elevation of circulating interleukin-6 after surgery: Factors influencing the serum level. Cytokine 1994; 6: 181-6.
31. Sato N, Koeda K, Kimura Y et al. Cytokine profile of serum and bronchoalveolar lavage fluids following thoracic esophageal cancer surgery. Eur Surg Res 2001; 33: 279-84.
32. Haga Y, Beppu T, Kouichi D. Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery. Crit Care Med 1997; 25: 1994-2000.
33. Hulscher J B F, van Sandick J W, de Boer A G E M et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347: 1662-9.
34. Sato N, Koeda K, Ikeda K et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg 2002; 236: 184-90.
35. Nakazawa K, Narumi Y, Ishikawa S et al. Effect of prostaglandin E1 on inflammatory responses and gas exchange in patients undergoing surgery for oesophageal cancer. Br J Anaesth 2004; 93: 199-203.
36. Atkinson M C. The use of N-acetylcysteine in intensive care. Crit Care Resusc 2002; 4: 21-7.